Novotech To Discuss Benefits To U.S. Biotech And Pharma Companies Conducting Clinical Trials In Australia This Week At Boston Biorelationships 2004

Published: Jun 01, 2004

Novotech CEO Alek Safarian will discuss the benefits to U.S. biotech and pharmaceutical companies conducting clinical trial research in Australia at this week's Biorelationships 2004 conference in Cambridge, MA. Safarian will discuss the independent contract research organization's work over the past three years with more than 15 U.S.-based pharmaceutical and biotech companies as well as many major European pharmas.

Back to news